Eribulin Mesylate

A Novel Halichondrin B Analogue for the Treatment of Metastatic Breast Cancer

Ali McBride, Pharm.D., M.S., BCPS; Sara K. Butler, Pharm.D., BCPS, BCOP


Am J Health Syst Pharm. 2012;69(9):745-755. 

In This Article


Eribulin mesylate is available as 1-mg vials for single-use infusion. Since the recommended dose is 1.4 mg/m2 i.v. on days 1 and 8 of a 21-day cycle, a woman with an average body surface area of 1.7 m2 would require 2.4 mg per dose, which equates to three vials of eribulin. The average wholesale price of eribulin is $1037 for the 1-mg/2 mL vial.[33] Each dose would cost approximately $2488, or $4977 per treatment cycle.


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.